| Ahlund et al 48
|
Sweden |
Postpartum supervised PFMT vs written instructions for PFMT postpartum |
24 wk. |
40 / 42 |
Clinical |
3 (2 / 0 / 1) |
| Aksac et al 14
|
Turkey |
Home PFMT vs Home PFMT + BF vs Control |
8 wk. |
20 / 20 / 10 |
UD |
3 (2 / 0 / 1) |
| Aukee et al 15
|
Finland |
Home PFMT vs Home PFMT + BF |
12 wk. |
15 / 15 |
UD |
3 (2 / 0 / 1) |
| Berghmans et al 16
|
Holland |
Supervised PFMT vs Supervised PFMT + BF |
4 wk. |
20 / 20 |
Clinical and/or UD |
4 (2 / 1 / 1) |
| Bo et al 23
|
Norway |
Home PFMT (12 contr. 3x/day) vs Supervised (45min/wk.) and home PFMT |
24 wk. |
29 / 23 |
UD and pad test
|
3 (2 / 0 / 1) |
| Bo et al 35
|
Norway |
Supervised PFMT vs IES (50Hz; 30min/day) vs Cones (20min/day) vs Control |
24 wk. |
25 / 25 / 27 / 30 |
UD and pad test
|
4 (2 / 1 / 1) |
| Bo et al 13
|
Norway |
Home and supervised PFMT vs Control |
24 wk. |
25 / 30 |
UD |
3 (2 / 0 / 1) |
| Borello et al 20
|
USA |
Supine PFMT vs Supine and standing PFMT |
9 to 12 wk. |
17 / 19 |
Clinical |
3 (2 / 0 / 1) |
| Cammu et al 42
|
Belgium |
PFMT + BF (30min 1x/wk.) vs Cones (15min. 2x/day) |
12 wk. |
30 / 30 |
UD |
3 (2 / 0 / 1) |
| Castro et al 36
|
Brazil |
Supervised PFMT vs IES(50Hz; 20min/day) vs Cones (25min 3x/wk.) vs Control |
24 wk. |
26 / 27 / 24 / 24 |
UD |
4 (2 / 1 / 1) |
| Correia et al 37
|
Brazil |
SES (50Hz; 20min; 2x/wk.) vs IES (50Hz; 20min; 2x/wk.) vs Control |
6 wk. |
15 / 15 / 15 |
Clinical |
3 (2 / 0 / 1) |
| De Oliveira et al 21
|
Brazil |
Group PFMT (45min, 2x/wk) vs Individual supervised PFMT (30min, 2x/wk) |
12 wk. |
30 / 30 |
UD |
4 (2 / 1 / 1) |
| Dumoulin et al 46
|
Canada |
Supervised PFMT vs Supervised PFMT + abdominal training vs Control |
8 wk. |
20 / 23 / 19 |
UD and pad test
|
4 (2 / 1 / 1) |
| Felicissimo et al 24
|
Brazil |
Home PFMT (90 a 180 contr./day) vs Supervised PFMT (50min, 2x/wk) + Home PFMT |
8 wk. |
30 / 29 |
UD |
3 (2 / 0 / 1) |
| Ferreira et al 25
|
Portugal |
Home PFMT (30 contr./day) vs Supervised (45min. 1x/wk) + home PFMT |
24 wk. |
17 / 17 |
UD |
3 (2 / 0 / 1) |
| Fitz et al 11
|
Brazil |
PFMT + BF (40min 2x/wk) vs Control |
4 wk. |
16 / 16 |
UD |
3 (2 / 0 / 1) |
| Gilling et al 50
|
New Zealand |
Magnetic stimulaion (10-50Hz, 20min, 3x/wk) vs Placebo/Sham |
6 wk. |
35 / 35 |
UD |
4 (2 / 1 / 1) |
| Harvey et al 43
|
Canada |
Supervised + home PFMT vs Cones |
6 wk. |
7 / 7 |
UD |
3 (2 / 1 / 0) |
| Hirakawa et al 17
|
Japan |
Home PFMT (2x/day) vs Home PFMT + BF (2x/day) |
12 wk. |
23 / 23 |
Clinical |
3 (2 / 0 / 1) |
| Kamel et al 45
|
Egypt |
Abdominal training (3x/wk) vs Supervised PFMT (3x/wk) |
12 wk. |
15 / 15 |
UD |
3 (2 / 0 / 1) |
| Kaya et al 29
|
Turkey |
Bladder training vs PFMT + bladder training |
6 wk. |
24 / 26 |
Clinical |
3 (2 / 0 / 1) |
| Knight et al 31
|
UK |
Supervised IES (35Hz; 35 min; 1x/10days) vs Home IES (10Hz, daily during night sleep) vs Home PFMT (6x/day) |
24 wk. |
19 / 20 / 18 |
UD |
3 (2 / 0 / 1) |
| Liebergall et al 49
|
Israel |
Paula Method (45min/day) vs Group + home PFMT |
12 wk. |
117 / 123 |
Pad test
|
3 (2 / 1 / 0) |
| Luber et al 34
|
USA |
IES (50Hz; 15min, 2x/day) vs Placebo/Sham |
12 wk. |
20 / 24 |
UD |
3 (2 / 1 / 0) |
| McLean et al 12
|
Canada |
Supervised + domestic PFMT vs Control |
12 wk. |
18 / 17 |
UD |
3 (2 / 0 / 1) |
| Miller et al 27
|
USA |
Pre-contraction (“Knack” ) vs Control |
1 wk. |
13 / 14 |
Clinical |
3 (2 / 0 / 1) |
| Morkved et al 18
|
Norway |
Supervised and domestic PFMT vs Supervised and domestic PFMT + BF |
24 wk. |
48 / 46 |
UD and pad test
|
4 (2 / 1 / 1) |
| Parsons et al 32
|
UK |
PFMT + IES vs PFMT + placebo vs PFMT + control |
14 wk. |
82 / 42 / 40 / 20 |
UD |
3 (1 / 1 / 1) |
| Pereira et al 22
|
Brazil |
Group PFMT (2x/wk, 60 min) vs Individual PFMT (2x/wk, 60 min) vs Control |
12 wk. |
15 / 15 / 15 |
Clinical |
3 (2 / 0 / 1) |
| Pereira et al 40
|
Brazil |
SES (50Hz; 20 min; 2x/wk.) vs Control |
6 wk. |
7 / 7 |
Clinical |
3 (2 / 0 / 1) |
| Pereira et al 41
|
Brazil |
PFMT (40 min; 2x/wk.; 100 contr.) vs Cones (40 min.; 2x/wk.) |
6 wk. |
13 / 15 / 15 |
Clinical |
3 (2 / 0 / 1) |
| Sand et al 39
|
USA |
IES (2x/d; frequency not reported) vs Placebo/Sham |
12 wk. |
28 / 16 |
UD |
4 (2 / 1 / 1) |
| Santos et al 44
|
Brazil |
IES (50Hz; 20 min; 2x/wk.) vs Cones (2x/wk; 45 min.) |
16 wk. |
24 / 21 |
Clinical |
3 (2 / 0 / 1) |
| Sherburn et al 30
|
Australia |
Supervised + home PFMT vs Bladder training |
20 wk. |
41 / 35 |
UD |
5 (2 / 2 / 1) |
| Terlikowski et al 33
|
Poland |
PFMT + IES (40Hz; 20 min; 2x/day) vs PFMT + placebo/sham |
8 wk. |
64 / 29 |
UD |
3 (2 / 0 / 1) |
| Wong et al 19
|
China |
PFMT + vaginal BF (2x/wk; 30min) vs PFMT + abdominal BF (to minimize abdominal contractions) |
12 wk. |
19 / 19 |
UD |
3 (2 / 0 / 1) |
| Zanetti et al 26
|
Brazil |
Home PFMT vs Supervised + home PFMT (2x/wk; 45min.) |
12 wk. |
21 / 23 |
UD |
3 (2 / 0 / 1) |